Showing results (1241-1250 of 9,924) with videos related to

Sort By:
Pageof 993
Bone Marrow Transplantation|November 1, 1989
Allogeneic transplantation of blood-derived, T cell-depleted hemopoietic stem cells after myeloablative treatment in a patient with acute lymphoblastic leukemiaA Kessinger, D M Smith, S E Strandjord, et al.
Bone Marrow Transplantation|April 15, 2023
Protection of haematopoietic progenitor cell donors: an updated overview of the European landscapeJacinto Sánchez Ibáñez, Arlinke Bokhorst, Akila Chandrasekar, et al.
Bone Marrow Transplantation|August 10, 2020
Chimeric antigen receptor T cell therapy in multiple myeloma: promise and challengesBinod Dhakal, Parameswaran N Hari, Saad Z Usmani, et al.
Bone Marrow Transplantation|April 6, 2023
Avapritinib is effective for treatment of minimal residual disease in acute myeloid leukemia with t (8;21) and kit mutation failing to immunotherapy after allogeneic hematopoietic stem cell transplantationJun Kong, Feng-Mei Zheng, Zhi-Dong Wang, et al.
Bone Marrow Transplantation|March 30, 2021
Iron overload in the HCT patient: a reviewPavan Tenneti, Aleksander Chojecki, Mary Ann Knovich
Bone Marrow Transplantation|April 14, 2015
Impact of ABO blood group mismatch in alemtuzumab-based reduced-intensity conditioned haematopoietic SCTC K Brierley, T J Littlewood, A J Peniket, et al.
Bone Marrow Transplantation|December 1, 1989
Autologous bone marrow or peripheral blood stem cell transplantation for patients with chronic myelogenous leukaemia in chronic phaseG Meloni, P De Fabritiis, G Alimena, et al.
Bone Marrow Transplantation|September 1, 1989
A comparison of DNA-RFLP typing with serology and mixed lymphocyte reaction in the selection of matched unrelated bone marrow donorsT M Clay, H P Jones, J L Bidwell, et al.
Bone Marrow Transplantation|March 31, 2023
Busulfan target exposure attainment in children undergoing allogeneic hematopoietic cell transplantation: a single day versus a multiday therapeutic drug monitoring regimenT Tim Bognàr, J S Jurjen Kingma, E H Erin Smeijsters, et al.
Bone Marrow Transplantation|March 31, 2023
Fludarabine/TBI 8 Gy versus fludarabine/treosulfan conditioning in patients with AML in first complete remission: a study from the Acute Leukemia Working Party of the EBMTGesine Bug, Myriam Labopin, Riitta Niittyvuopio, et al.
Pageof 993